{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:14:27Z","timestamp":1763003667761,"version":"3.45.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001738","name":"Be The Match Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","award":["NCT04443907"],"award-info":[{"award-number":["NCT04443907"]}],"id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jtct.2023.03.027","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T05:05:10Z","timestamp":1680066310000},"page":"452.e1-452.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"29","author":[{"given":"Rupa","family":"Narayan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Niroula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-6843","authenticated-orcid":false,"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Kuxhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everett","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9554-1058","authenticated-orcid":false,"given":"Yi-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-0533","authenticated-orcid":false,"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer","family":"Beitinjaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiga","family":"Nishihori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-2081","authenticated-orcid":false,"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-2138","authenticated-orcid":false,"given":"Valerie I.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek","family":"Kamoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5286-1329","authenticated-orcid":false,"given":"Miguel A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-0445","authenticated-orcid":false,"given":"Muhammad Bilal","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhat","family":"Askar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Kanakry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-6518","authenticated-orcid":false,"given":"Loren","family":"Gragert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-6120","authenticated-orcid":false,"given":"Yung-Tsi","family":"Bolon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2855-4120","authenticated-orcid":false,"given":"Steven G.E.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahinaz M.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-2775","authenticated-orcid":false,"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-8252","authenticated-orcid":false,"given":"Stephen","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.03.027_bib0001","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtct.2023.03.027_bib0002","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.03.027_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219547","article-title":"Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin","volume":"14","author":"Narayan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2023.03.027_bib0004","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI97482","article-title":"Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia","volume":"129","author":"van der Lee","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2023.03.027_bib0005","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2011-11-394395","article-title":"Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia","volume":"120","author":"Greiner","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0006","doi-asserted-by":"crossref","first-page":"869","DOI":"10.18632\/oncotarget.26617","article-title":"Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia","volume":"10","author":"Forghieri","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtct.2023.03.027_bib0007","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood-2013-02-481945","article-title":"Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3\/4\/5 associate with adverse outcomes in hematopoietic stem cell transplantation","volume":"121","author":"Fern\u00e1ndez-Vi\u00f1a","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0008","first-page":"362","article-title":"HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation","volume":"136","author":"Petersdorf","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0009","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2013-10-532671","article-title":"Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation","volume":"123","author":"Fernandez-Vi\u00f1a","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0010","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2014-09-599969","article-title":"HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation","volume":"124","author":"Petersdorf","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0011","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2023.03.027_bib0012","unstructured":"DTU Health Tech. NetMHCpan - 4.0. Pan-specific binding of peptides to MHC class I alleles of known sequence. Available at: https:\/\/services.healthtech.dtu.dk\/service.php?NetMHCpan-4.0."},{"key":"10.1016\/j.jtct.2023.03.027_bib0013","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/bib\/bbz051","article-title":"A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction","volume":"21","author":"Mei","year":"2020","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jtct.2023.03.027_bib0014","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0016","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtct.2023.03.027_bib0017","article-title":"MHCflurry: open-source class I MHC binding affinity prediction","volume":"7","author":"O'Donnell","year":"2018","journal-title":"Cell Syst"},{"key":"10.1016\/j.jtct.2023.03.027_bib0018","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","article-title":"MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing","volume":"11","author":"O'Donnell","year":"2020","journal-title":"Cell Syst"},{"key":"10.1016\/j.jtct.2023.03.027_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-374279-7.06004-5","article-title":"Immune epitope database and analysis resource","volume":"2","author":"Fleri","year":"2016","journal-title":"Encyclopedia of Immunobiology"},{"key":"10.1016\/j.jtct.2023.03.027_bib0020","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V124.21.1230.1230","article-title":"Allogeneic hematopoietic cell transplantation in AML with normal karyotype and NPM1 mutated FLT3-ITD negative: a retrospective analysis from the Acute Leukemia Working Party of EBMT","volume":"124","author":"Bazarbachi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0021","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.3324\/haematol.2015.135681","article-title":"Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status","volume":"101","author":"Bazarbachi","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.03.027_bib0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ajh.25355","article-title":"Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission","volume":"94","author":"Poir\u00e9","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.03.027_bib0023","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1200\/JCO.2013.54.4973","article-title":"Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial","volume":"33","author":"R\u00f6llig","year":"2014","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2023.03.027_bib0024","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1182\/blood-2018-99-113662","article-title":"Pre-transplant NPM1 mutant transcript level is highly predictive of outcome after allograft and thresholds are dependent on FLT3 ITD status","volume":"132","author":"Dillon","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0025","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1182\/blood.2019002959","article-title":"Molecular MRD status and outcome after transplantation in NPM1-mutated AML","volume":"135","author":"Dillon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0026","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1507471","article-title":"Assessment of minimal residual disease in standard-risk AML","volume":"374","author":"Ivey","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.03.027_bib0027","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1182\/blood-2018-01-828467","article-title":"High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML","volume":"131","author":"Patel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0028","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.25544","article-title":"High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia","volume":"94","author":"Patel","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.03.027_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007757","article-title":"Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system","volume":"16","author":"Paul","year":"2020","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.jtct.2023.03.027_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jtct.2023.03.027_bib0031","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2020.10.004","article-title":"A snapshot of human leukocyte antigen (HLA) diversity using data from the Allele Frequency Net Database","volume":"82","author":"Gonzalez-Galarza","year":"2021","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtct.2023.03.027_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127637","article-title":"Altered HLA class I profile associated with type A\/D nucleophosmin mutation points to possible anti-nucleophosmin immune response in acute myeloid leukemia","volume":"10","author":"Ku\u017eelov\u00e1","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2023.03.027_bib0033","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1200\/JCO.2011.41.1116","article-title":"Donor lymphocyte infusion induces polyspecific CD8(+) T-cell responses with concurrent molecular remission in acute myeloid leukemia with NPM1 mutation","volume":"31","author":"Hofmann","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.027_bib0034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/jcm9010039","article-title":"Immunological and clinical impact of manipulated and unmanipulated DLI after allogeneic stem cell transplantation of AML patients","volume":"9","author":"Greiner","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtct.2023.03.027_bib0035","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.exphem.2010.07.002","article-title":"Streptamer-based selection of WT1-specific CD8+ T cells for specific donor lymphocyte infusions","volume":"38","author":"Wang","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtct.2023.03.027_bib0036","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41375-019-0414-z","article-title":"Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy","volume":"33","author":"Bae","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.03.027_bib0037","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood.2020009471","article-title":"Clinical effects of administering leukemia-specific donor T cells to patients with AML\/MDS after allogeneic transplant","volume":"137","author":"Lulla","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.027_bib0038","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41551-020-00625-5","article-title":"CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia","volume":"5","author":"Xie","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jtct.2023.03.027_bib0039","doi-asserted-by":"crossref","unstructured":"Linde MH, Fan AC, Kohnke T, et al. Reprogramming cancer into antigen presenting cells as a novel immunotherapy [e-pub ahead of print]. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0502.","DOI":"10.1158\/2159-8290.CD-21-0502"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723012046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723012046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:11:20Z","timestamp":1763003480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723012046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2666636723012046"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.03.027","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}